Absci
ISIN US00091E1091
|WKN A3CVW3
Market cap (in EUR)
311.27 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Healthcare Healthcare Services Miscellaneous Healthcare United States
Financials
Key metrics
| Market capitalisation, EUR | 311.27 m |
| EPS, EUR | -0.86 |
| P/B ratio | 1.77 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 4.19 m |
| Net income, EUR | -95.32 m |
| Profit margin | -2,274.06% |
What ETF is Absci in?
There are 7 ETFs which contain Absci. All of these ETFs are listed in the table below. The ETF with the largest weighting of Absci is the ARK Genomic Revolution UCITS ETF USD Accumulating.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
